Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate. It contains a a protease-sensitive Val-Cit dipeptide, and a MMAE payload. The MMAE is a synthetic antineoplastic agent. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.

Molecular structure of the compound BP-23465
    • Unit
    • Price
    • Qty
    • 5 MG
    • $540.00
    • 10 MG
    • $760.00
    • 25 MG
    • $1100.00
    • 50 MG
    • $1600.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?

Product Citations

  1. Paige E. Pistono, Paul Huang, Daniel D. Brauer, Matthew B. Francis Fitness Landscape-Guided Engineering of Locally Supercharged Virus-like Particles with Enhanced Cell Uptake Properties. ACS Chemical Biology. 2022